MET.NYSEMetlife INC

Form 4: MetLife EVP Bill Pappas Sells $27,000 in Common Stock

Sentiment:

SEC Form 4 Filing


Bill Pappas, EVP of Global Technology & Operations at MetLife, sold 27,000 shares of common stock on March 18, 2024, at an average price of $72.2713.

Summary

  • On March 18, 2024, Bill Pappas, the EVP of Global Technology & Operations at MetLife, sold 27,000 shares of MetLife common stock.
  • The sale was executed at a weighted average price of $72.2713 per share.
  • The price range for the shares sold was between $72.26 and $72.31.
  • Following the transaction, Pappas directly owns 57,768 shares of MetLife common stock.
  • Pappas also indirectly owns 7,900 shares through a 2022 GRAT and 17,300 shares through a 2023 GRAT.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing related to an insider stock sale. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about the transaction.

Industry Context

Form 4 filings are standard disclosures required by the SEC when corporate insiders, like executives and directors, trade their company's stock. These filings are closely watched by investors for insights into management's perspective on the company's value and future prospects.

Stakeholder Impact

  • The stock sale by a high-ranking executive could be perceived in various ways by stakeholders.
  • Some might see it as a lack of confidence in the company's future, while others might view it as a personal financial decision.

Key Dates

DateDescription
03/18/2024Date of the stock sale transaction.
03/20/2024Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.